, Tracking Stock Market Picks
Enter Symbol:
Anacor Pharmaceuticals Inc (ANAC) [hlAlert]

up 2,411.65 %

Anacor Pharmaceuticals Inc (ANAC) rated Buy with price target $8 by Capstone Investments

Posted on: Tuesday,  Dec 4, 2012  9:25 AM ET by Capstone Investments

Capstone Investments rated Buy Anacor Pharmaceuticals Inc (NASDAQ: ANAC) on 12/04/2012, when the stock price was $5.32. Since
then, Anacor Pharmaceuticals Inc has gained 2411.65% as of 01/26/2016's recent price of $133.62.
If you would have followed this Capstone Investments's recommendation on ANAC, you would have gained 2411.65% of your investment in 1148 days.

Anacor Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing small-molecule therapeutics derived from its boron chemistry platform. The Company has five product candidates in clinical development. Its three product candidates include two topically administered dermatologic compounds: AN2690, an antifungal for the treatment of onychomycosis, and AN2728, an anti-inflammatory for the treatment of psoriasis, as well as a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria GSK2251052 (GSK '052). The Company is developing AN2718 as a topical antifungal product candidate for the treatment of onychomycosis and skin fungal infections, and AN2898 as a topical anti-inflammatory product candidate for the treatment of psoriasis and atopic dermatitis. In August 2010, it entered into a research agreement with Eli Lilly and Company (Lilly).

Capstone Investments
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/4/2012 9:25 AM Buy
5.32 8.00
as of 12/31/2012
1 Week up  1.56 %
1 Month down  -2.25 %
3 Months   
1 YTD down  -2.25 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy